These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9690411)

  • 41. Acute renal failure following ACE inhibition in a patient with coarctation of the aorta.
    Sever MS; Sönmez B
    Nephrol Dial Transplant; 1996 Aug; 11(8):1643-4. PubMed ID: 8856229
    [No Abstract]   [Full Text] [Related]  

  • 42. Genetic Studies in Infants with Congenital Nephrotic Syndrome: A Case Series.
    Karunakar P; Chidambaram AC; Krishnamurthy S; Sivamurukan P; Deepthi B; Gowda M
    Saudi J Kidney Dis Transpl; 2023 Mar; 34(2):191-195. PubMed ID: 38146730
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The changing face of childhood nephrotic syndrome.
    Chesney R
    Kidney Int; 2004 Sep; 66(3):1294-302. PubMed ID: 15327442
    [No Abstract]   [Full Text] [Related]  

  • 44. Diuretics potentiate the angiotensin converting-enzyme inhibitor-associated acute renal dysfunction.
    Lee HC; Pettinger WA
    Clin Nephrol; 1992 Oct; 38(4):236-7. PubMed ID: 1424316
    [No Abstract]   [Full Text] [Related]  

  • 45. [The treatment of mild and moderate arterial hypertension with enalapril. A multicenter study of enap and enap-HL in Russia].
    Ol'binskaia LI
    Ter Arkh; 1997; 69(8):86-8. PubMed ID: 9381405
    [No Abstract]   [Full Text] [Related]  

  • 46. [Vasomotor (nitritoid) reactions induced by sodium aurothiomalate and enap].
    Murav'ev IuV; Tsapina TN
    Ter Arkh; 2002; 74(5):79-80. PubMed ID: 12087916
    [No Abstract]   [Full Text] [Related]  

  • 47. [ACE inhibitors and cough].
    Kobayashi S; Kawakami Y; Hirabayashi T
    Kokyu To Junkan; 1990 Aug; 38(8):763-7. PubMed ID: 2218084
    [No Abstract]   [Full Text] [Related]  

  • 48. Angiotensin-converting enzyme inhibitors and glycosuria.
    Milavetz JJ; Popovtzer MM
    Arch Intern Med; 1992 May; 152(5):1081-3. PubMed ID: 1316108
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renal artery stenosis and ACE inhibitor.
    Sterner G
    J Intern Med; 1990 Nov; 228(5):541. PubMed ID: 2254726
    [No Abstract]   [Full Text] [Related]  

  • 50. Efficacy and safety of a new angiotensin-converting enzyme inhibitor, ramipril, vs. enalapril in essential hypertension: a multicenter trial.
    Mroczek WJ
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S147-9. PubMed ID: 1725028
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Renpress, Sandopril (Spirapril/TI 211-950). Summary of chemical, pharmacological and clinical properties.
    Jerie P; Kremer HJ
    Cor Vasa; 1992; 34(1):82-7. PubMed ID: 1288944
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of enalapril on lipid profile in diabetic and non-diabetic essential hypertensive patients.
    Satia MC; Shukla ML; Goyal RK
    Indian J Physiol Pharmacol; 1996 Jan; 40(1):83-6. PubMed ID: 8864777
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enalapril treatment of proteinuria in normotensive children.
    Sasinka MA; Podracka L; Boor A; Jurkovic I; Mitro A; Kovacs L
    Bratisl Lek Listy; 1999 Sep; 100(9):476-80. PubMed ID: 10645036
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Therapeutic approach to the nephrotic syndrome in children].
    Barras MH; Guignard JP
    Rev Med Suisse Romande; 1992 Jul; 112(7):645-51. PubMed ID: 1496216
    [No Abstract]   [Full Text] [Related]  

  • 55. Angiotensin-converting enzyme inhibitors and anemia in chronic kidney disease: a complex interaction.
    Abu-Alfa AK; Perazella MA
    Am J Kidney Dis; 2002 Apr; 39(4):896-7. PubMed ID: 11920360
    [No Abstract]   [Full Text] [Related]  

  • 56. [Combination therapy of arterial hypertension combined with liver pathology. The place of angiotensin converting enzyme inhibitors].
    Lazebnik LB; Komissarenko IA; Mikheeva OM; Drozdov VN; Sil'vestrova SIu; Petrakov AV
    Kardiologiia; 2009; 49(3):28-33. PubMed ID: 19257863
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Blood pressure lowering by the ACE-inhibitor spirapril. "24-hour efficacy of real once daily application of spirapril (HERAS Study)"].
    Düsing R; Müller U
    MMW Fortschr Med; 2003 Oct; 145(40):46. PubMed ID: 14603605
    [No Abstract]   [Full Text] [Related]  

  • 58. Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy.
    Barnett AH; Bain SC; Bouter P; Karlberg B; Madsbad S; Jervell J; Mustonen J;
    N Engl J Med; 2004 Nov; 351(19):1952-61. PubMed ID: 15516696
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of the angiotensin-converting enzyme inhibitor enalapril on post-transplant erythrocytosis.
    Marubayashi S; Yamamoto H; Shibata S; Fudaba Y; Miyata Y; Fukuma K; Okada K; Hinoi T; Ikeda M; Maeda T; Oshiro Y; Dohi K
    Hiroshima J Med Sci; 1998 Sep; 47(3):121-4. PubMed ID: 9810784
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Changes in kidney function during treatment of heart failure patients with ACE inhibitors].
    Dietz R; Nagel F; Osterziel KJ
    Verh Dtsch Ges Inn Med; 1991; 97():545-8. PubMed ID: 1667051
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.